Starter Grants for Clinical Lecturers

These grants provide up to £30,000 over 1-2 years for consumables, to support Clinical Lecturers who are looking to develop and strengthen their research careers.

Key dates

Round 16 is now closed

The Panel will convene in December, with the results and feedback sent out in early 2017.

The next round will open in January 2017.

Starter Grants for Clinical Lecturers offer funding of up to £30,000 to cover the cost of research consumables. The grants allow research-active Clinical Lecturers to gather data to strengthen their bids for longer-term fellowships and funding.

To read case studies on Starter Grant holders, click here.

About the scheme

This scheme was launched in October 2008 as a partnership between the Academy and the Wellcome Trust, and we were delighted to welcome the British Heart Foundation in 2011, Arthritis Research UK in 2012, the Medical Research Council in 2013, and the Royal College of Physicians in 2014. In 2016 we warmly welcome our most recent funder to the consortium, Diabetes UK.

The grants provide modest ‘starter’ funds to enable research active Clinical Lecturers to pursue their research work. Clinical Lecturer posts provide a salary but often do not come with the funding to support the costs of the research. This scheme was designed to help bridge this gap by providing Clinical Lecturers with access to modest research funds for up to two years. It gives them experience of preparing a research grant application and helps them establish their research portfolios by providing funding for research consumables.

So far we have supported approximately 315 Clinical Lecturers through 14 rounds of funding, with grants totalling nearly £9 million. In 2011, the Academy and the Wellcome Trust carried out a review of the scheme, which you can download from the right hand side of this page.

In December 2013, we launched the Winter Science Meeting for Starter Grant Holders, an annual event organised exclusively for Starter Grant Holders. For more information please visit the main Winter Science Meeting page.

The grants are intended as start-up funding and as such are not intended for applicants who have already obtained substantial funding through, for example, Clinician Scientist Fellowships, New Investigator Awards or large project grants.

All eligible applicants must:

1.   Have a PhD or MD.

2.   Hold a medical, dental or veterinary undergraduate degree and be registered with the General Medical Council, General Dental Council or Royal College of Veterinary Surgeons.

3.   Hold a clinical contract.

If you are a clinician in human or dental medicine, you must also:

1.   Be a research-active Clinical Lecturer

2.   Hold an NTN or NTN(A)

3.   Be within higher specialty training.

4.   Have undertaken a substantial period of research equivalent to a PhD or research MD, if you have qualified abroad with an MD.

5.   Note the following eligibility criteria relating to the timing of your CCT:

  • If your CCT date will fall during the course of your proposed project, at least half of the project must take place prior to the estimated CCT date. In this case, applicants must have secured protected research time throughout the proposed project (including the part taking place post-CCT).
  • Clinical Lectureships in Primary Care are awarded post-CCT and we welcome applications from this group. However, for all other specialties, candidates are not eligible to apply if they have already attained their CCT.

Senior Clinical Lecturers and Clinical Psychologists are not eligible for this scheme.

If you are a clinician in veterinary medicine, you must be either:

1.   A research-active Veterinary Specialist in Training (Resident/Senior Clinical Training Scholar) within an approved Specialist Training Programme with secured and protected research time throughout the proposed project.


2.   A research-active Veterinary Clinician or Veterinary Pathologist with Veterinary Specialist Board qualification or eligibility and within the 3 year (probationary) period of your first University appointment and with secured and protected research time throughout the proposed project. If your position is that of a Senior Lecturer but are still within the three year probationary period then you are still eligible for this scheme.


Please contact the grants team if you have any other queries about the scheme on 020 3176 2159, or email us at

This scheme is targeted at those who are in the earlier years of their Clinical Lecturer appointment. You should not already have obtained substantial funding from other sources, for example a Clinician Scientist Fellowship, New Investigator Award or large project grant.

The maximum grant available is £30,000. This can be spread over one to two years to contribute towards directly incurred research costs such as consumables and equipment.

Grants cannot be used to pay for your personal salary costs or to employ research assistants, PhD students or postdoctoral staff. 

The Academy recognises the challenges clinicians face when managing a clinical and a research career with family and caring commitments. During the review process, prior career breaks will be taken into account when evaluating a candidate’s research output and progress. If you are successful, you will be able to apply for a no-cost extension to your grant to account for periods of absence or delays in your project during your award. For an example of the success such Starter Grant holders can achieve, please click here.

Successful applicants cannot reapply. Unsuccessful applicants are limited to one resubmission.

Like all UK post-doctoral clinicians, Starter Grant holders are eligible for the Academy's one-to-one mentoring scheme and are encouraged to contact the Office regarding this.

The current members of the selection panel are:

Professor Marina Botto FMedSci (chair), Imperial College London

Professor Wiebke Arlt FMedSci, University of Birmingham

Professor Edwin Chilvers FMedSci, University of Cambridge

Professor Hilary Critchley FRSE FMedSci, University of Edinburgh

Professor Carol Dezateux CBE FMedSci, University College London

Professor David Edwards FMedSci, King's College London

Professor Michael Frenneaux FMedSci, University of East Anglia

Professor Nigel Leigh FMedSci, University of Sussex

Professor David Neal CBE FMedSci, University of Oxford


Applicants should not approach Panel members to discuss their application. All queries should be directed to the Panel secretariat on

All Starter Grant Holders are required to report via Researchfish annually by the end of March each year throughout their grant and for three years after the completion of their award. Click here for full reporting instructions.

A report of Starter Grant Holders' research outcomes submitted to us during our first Researchfish submission window in 2014 is available for download on the right hand side of this page.

You will also need to submit (via email to a Final Expenditure Report within 3 months of the end of your grant in addition to submitting Researchfish data. You can download the final expenditure form from the right hand side of this page.

Recent Awardees

James Alix, University of Sheffield, Developing in vivo Raman Spectroscopy for neuromuscular disease

Rahul Bhatnagar, University of Bristol, The Semi-rigid Pleuroscopy In Routine Pleural Infection (SPIRIT) Trial

Adam Brown, University of Cambridge, Integration of anatomical imaging and biomechanics for the|prediction of coronary plaque growth and rupture

Manil Chouhan, UCL, Hameodynamic assessment of beta-blocker therapy for portal hypertension using magnetic resonance imaging

Thomas Darton, University of Sheffield, Investigating the effects of environmental exposure to fluoroquinolone-resistant Enterobacteriaceae on the gastrointestinal microbiota of children in Nepal

Antonio de Marvao, Imperial College London, Left ventricular hypertrophy in West Africans: discovery of genetic and environmental determinants using 3D imaging-genetics

Charlotte Elder, University of Sheffield, The pharmacokinetic evaluation of a novel non-invasive Short Synacthen Test in Children

David Eyre, University of Oxford, Complete bacterial genome sequencing and mathematical modelling to control healthcare-associated infection

Montserrat Fuste Boadella, King's College London, Identifying gene expression and neuroimaging markers for postpartum psychosis

Sherif Gonem, University of Leicester, Effect of environmental exposures on asthma symptoms, lung function and airway inflammation

Sara Hillman, UCL, An integrated multi-omic analysis of human T-regulatory cells and their role in pregnancies affected by pre-eclampsia

Rachel Jennings, University of Manchester, Molecular dissection of the transcriptome regulating differentiation from the early human embryonic pancreas.

Dan Jones, Queen Mary University of London, The investigation of the effect of inorganic nitrite/nitrate on contrast induced nephropathy (CIN) after percutaneous coronary intervention (PCI).

Alasdair Jubb, University of Cambridge, Quantifying glucocorticoid induced chromatin reorganisation and genomic responses in human monocytes

Yee-Haur Mah, St George's University of London, Unified high-dimensional modelling of chronic and acute|injury in stroke

Benedict Michael, University of Liverpool, Identifying adjunctive therapy targets to mitigate leucocyte infiltration in herpes simplex encephalitis

Samiul Mostafa, University of Oxford, Determining optimal cardiovascular risk factor levels for individuals with type 2 diabetes mellitus (T2DM)

Amara Nwosu, University of Liverpool, The study of hydration status and complex symptoms in advanced cancer using bioelectrical impedance vector analysis (BIVA): a multi-site longitudinal cross-sectional|mixed-methods study

Aghogho Odudu, University of Manchester, Oxygenation and perfusion imaging as a novel biomarker of disease progression in diabetic kidney disease

Rashmi Patel, King's College London, Symptom dimensions in first episode psychosis: predicting clinical outcomes using natural language processing

Gary Reynolds, Newcastle University, Genomic analysis of immune populations in giant cell arteritis

Aidan Rose, University of Dundee, Investigating Pro-oncogenic Activin Driven Proliferation and Clonagenicity in Human Cutaneous Squamous Cell Carcinoma

Alexander Rothman, University of Sheffield, Inhibition of SMURF1 for the treatment of pulmonary arterial hypertension

William Sedley, Newcastle University, Sensory precision in the causation and treatment of tinnitus

Maisa Seppala, King's College London, Odontomes as prognostic markers for disrupted WNT signalling

Markus Sikkel, Imperial College London, Enhancing the Therapeutic Index of Anti-arrhythmic Agents In Ischaemia through use of Hypoxia Activated Pro-drugs

Nicole Stoesser, University of Oxford, Genomic epidemiology of carbapenem resistance gene transmission amongst Enterobacteriacaeae in hospital drainage reservoirs

Peter Swoboda, University of Leeds, Assessment of the cardiovascular consequences of enforced abstinence from exercise

Rhys Thomas, Cardiff University, The neuronal glucose transporter in genetic generalised epilepsy

Naomi Walker, London School of Hygiene and Tropical Medicine, Matrix Degradation Products for TB diagnosis & prediction of TBImmune reconstitution inflammatory syndrome (IRIS)

Arash Yavari, University of Oxford, Defining the role of AMP-activated protein kinase signalling in the pathogenesis of atrial arrhythmia

Dr Sara Ajina, University of Oxford, Neural effects of rehabilitation following visual cortex damage

Dr Robert Aldridge, UCL, Public Health Informatics in the era of big data: estimating future burden of disease in England using electronic health records

Mr James Chan, University of Oxford, Upregulation of alarmins to accelerate fracture repair in normal and osteoporotic bone

Dr Andrew Douglas, University of Southampton, Therapeutic epigenetic manipulation of C9orf72 for amyotrophic lateral sclerosis and frontotemporal dementia

Dr Louis Grandjean, UCL, The Genomics of Multidrug-Resistant Tuberculosis Transmission

Dr Gordon Hutchins, University of Leeds, Towards an understanding of molecular heterogeneity in gastric cancer

Mr Farhad Iranpour Boroujeni, Imperial College London, Computer assisted patellofemoral joint surgery: Application of a novel technique for assessing dynamic patellar tracking and contact patterns in patellofemoral instability

Dr Kerri Jane Kinghorn, King's College London, Dissecting the mechanisms of pathogenesis of TBK1 mutations using ALS Drosophila models

Dr Helena Lee, University of Southampton, Oral Dopamine Replacement in the Developing Albino Retina - A Proof of Concept Study

Dr Stephen McAdoo, Imperial College London, Defining the role of SYK in the pathogenesis of experimental and clinical glomerulonephritis

Dr Roly Megaw, University of Edinburgh, In vivo correction of a human mutation in a mouse model of retinitis pigmentosa

Dr Christopher Moxon, University of Liverpool, Investigating sequestration driven pathology in cerebral malaria in vitro and post-mortem using transcriptomics

Dr Hani Nazzal, University of Leeds, Decellularisation of dental pulp for use as a scaffold in regenerative endodontics

Dr Elisabeth Rounis, University of Oxford, The neural correlates of affordance during grasp

Dr Adam Sharp, Institute of Cancer Research, Co-regulatory proteins of the androgen receptor and androgen receptor splice variants: A novel therapeutic strategy for the treatment of castration-resistant prostate cancer

Dr James Tomlinson, Imperial College London, Gene expression profiling of the proximal tubule in kidney fibrosis

Dr Rick Adams, University College London (UCL), Investigating the role of D2 receptors in cognition

Dr Emma Beddowes, University of Cambridge, Non-invasive monitoring to predict treatment response and resistance in metastatic breast cancer patients

Mr Ricky Bhogal, University of Birmingham, Molecular, Proteomic and Metabolomic Characterisation of Peri-portal and Peri-venular Human Hepatocytes During Hypoxia

Major Richard Blanch, University of Birmingham, Defining markers for traumatic optic neuropathy

Miss Natalie Blencowe, University of Bristol, Improving the design of RCTs in surgery: understanding how to describe and standardise co-interventions 

Dr Katherine Bull, University of Oxford, A systematic screen to identify pathways involved in maintenance of the glomerular filtration barrier

Dr Andrew Conway Morris, University of Cambridge, Defining the pathways involved in PI3Kdelta-mediated neutrophil dysfunction

Dr Natalie Cooper, Barts and The London, Queen Marys School of Medicine and Dentistry, Core Outcome Set for Heavy Menstrual Bleeding

Dr Jennifer Dickens, University of Cambridge, Understanding the pathogenesis of idiopathic pulmonary fibrosis through the study of monogenic inherited syndromes

Dr Benjamin Fairfax, University of Oxford, A pilot investigation into genotypic determinants of melanocyte transcription, epigenetics and response to ultraviolet radiation.

Dr Jonathan Fishman, University College London (UCL), A tissue-engineered approach to laryngeal regeneration

Dr Hannah Gill, University of Bristol, Does xenon in combination with sevoflurane protect against anaesthesia-induced neurodegeneration in the developing brain?

Dr Nikos Gorgoraptis, Imperial College London, Understanding short-term memory dysfunction in post-traumatic amnesia to identify new outcome measures in traumatic brain injury.

Dr Golam Khandaker, University of Cambridge, Examination of causal pathways between inflammation, depression and psychosis using immune and genetic biomarkers in two British cohorts

Dr Regent Lee, University of Oxford, Integrated proteomics and metabolomics for discovery of novel molecular profiles associated with Abdominal Aortic Aneurysm progression

Dr Ian Logan, Newcastle University, Role of Transcriptional Regulators in Renal Fibrosis

Dr Jackie Maybin, University of Edinburgh, Is hypoxia required for hypoxia-inducible factor stabilisation at menstruation to drive efficient endometrial repair and limit menstrual blood loss?

Dr Fergus McCarthy, King's College London, The Role of the Unfolded Protein Response in the Aetiology and Prediction of Pre-eclampsia

Dr Geraldine O'Hara, London School of Hygiene and Tropical Medicine, Hepatitis B and Schistosomiasis – a potential interaction?

Dr Ashish Patel, King's College London, Combination Delivery of Monocytes and Adipose-Derived Stem Cells for Revascularisation of the Ischaemic Limb

Dr David Pinato, Imperial College London, Identification of molecular determinants underlying sorafenib resistance in hepatocellular carcinoma

Mr Stuart Robinson, Newcastle University, Epigenetic cross talk between tumour and the innate immune system in colorectal liver metastases

Dr Athanasios Saratzis, University of Leicester, Pilot-feasibility study ahead of “Bicarbonate with hydration to prevent acute renal injury after endovascular aneurysm repair (HYDRA), a randomized controlled trial”

Dr Elaine Soon, University of Cambridge, Identifying the role of GCN2 in the pathogenesis of pulmonary hypertension

Dr Helen Stuart, University of Manchester, Genetics and biology of voiding dysfunction

Dr Mark Teo, University of Leeds, Optimising Mesorectal Irradiation for Organ Preservation in Early Rectal Cancer

Dr Rimona Weil, University College London (UCL), Vision in Parkinson’s Disease

Dr Mohamed Badr, University of Sheffield: Bioengineered hypertrophic cartilage, a graft substitute for repair of bone defects

Miss Beatrix Elsberger, University of Dundee: YAP1 signalling expression in HER2 positive breast cancer

Mr Adam Frampton, Imperial College London: Revealing new microRNAs involved in Epithelial-to-Mesenchymal Transition (EMT) in Pancreatic Cancer

Dr Fieke Froeling, Imperial College London: Mechanisms of epigenetic regulation of drug resistance in pancreatic cancer

Dr Martin Gillies, University of Oxford: Electrophysiological study of the human deep brain during cognition

Dr Sumit Gupta, University of Leicester: Right Heart Dysfunction and Pulmonary Hypertension Evaluation in AIrway Diseases Using CMR

Dr Sandeep Hothi, University of Cambridge: Novel mechanisms and therapeutic targets in adrenergically mediated ventricular arrhythmia

Dr Peter MacPherson, University of Liverpool: Quality of Life in UK Adults with Multidrug Resistant Tuberculosis: A Prospective Cohort Study

Dr Sandra McAllister, Queen's University Belfast: Investigating the role of endothelial progenitor cells in skin graft revascularisation

Dr Christopher Miller, University of Manchester: Imaging myocardial inflammation with ultrasmall superparamagnetic particles of iron oxide

Dr Karwan Moutasim, University of Southampton: Integrin αvβ6 as a regulator of the tumour microenvironment and potential target in head and neck cancer

Dr Amit Patel, Imperial College London: Bone marrow derived allogeneic mesenchymal stromal stem cells (MSCs) for adults with septic shock

Dr Brijesh Patel, Imperial College London: Survival and death signals in experimental ARDS

Dr Brendan Payne, Newcastle University: Does the clonal expansion of mutations mediate mitochondrial ageing?

Dr Ruth Pepper, University College London (UCL): The role of calprotectin in human and experimental vasculitis.

Dr Noemi Roy, University of Oxford: Investigating the function of Codanin1 in haematopoietic cells: creating and analysing a murine conditional knock-out of Cdan1

Dr Tom Russ, University of Edinburgh: Urinary proteomic profile as a biomarker for preclinical dementia and cognitive ageing

Mr Prakash Saha, King's College London: Investigating the link between venous thrombosis and atherosclerosis

Dr Ian Scott, King's College London: Identifying Genetic Predictors of Radiological Damage in Rheumatoid Arthritis

Dr Roslyn Simms, University of Sheffield: Functional kidney magnetic resonance imaging (MRI) to identify novel biomarkers of disease progression in Autosomal Dominant Polycystic Kidney Disease

Dr Lola Solebo, University College London (UCL): National study of primary intraocular lens implantation in children under 2 years old (IoLunder2)

Dr Kyla Thomas, University of Bristol: Use of novel case-only methods to investigate the neuropsychiatric and cardiovascular safety of varenicline in the UK Clinical Practice Research Datalink

Dr Charlotte Warren-Gash, University College London (UCL): Specific respiratory infections as vascular triggers: a self-controlled case series analysis using linked LabBase and Hospital Episode Statistics data

Dr Emma Yu, University of Cambridge: Mitochondrial dysfunction, inflammation and treatment in atherosclerosis


The scheme is generously supported by the Wellcome Trust, Medical Research Council, British Heart Foundation, Arthritis Research UK, Royal College of Physicians and Diabetes UK.

Staff lead

Staff lead